Pierre-Yves Brillet

Sorbonne Université

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Salim Si-mohamed

Université Claude Bernard Lyon 1

FRANCE

View details

Jean-François BERNAUDIN

FRANCE

View details

Hannes Devos

Vrije Universiteit Brussel

BELGIUM

View details

Boris Duchemann

FRANCE

View details

dominique Valeyre

Université Paris 1 Panthéon-Sorbonne

FRANCE

View details

Raphael Borie

INSERM

FRANCE

View details

Federica Cacciamani

Laureate Institute for Brain Research

FRANCE

View details

Emmanuel Martinod

FRANCE

View details

Patricia Van der Niepen

Vrije Universiteit Brussel

BELGIUM

View details

Thomas Gille

MCU-PH (Assoc. Prof.)

FRANCE

View details

Yurdagul Uzunhan

Sorbonne Université

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pierre-Yves Brillet

Research Interests

Explore related searches

Contact this professor

Articles (20)

What is personalized lung poromechanical modeling and how can it improve the understanding and management of fibrotic interstitial lung diseases?

Relapsing polychondritis: tracheobronchial involvement and differential diagnoses.

Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial

Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis

Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort.

A 24/7 Pilot Remote Emergency Multidisciplinary Discussion for Rapidly Progressive Interstitial Lung Disease: A 2-Year Experience.

[Tracheobronchial involvement in relapsing polychondritis and differential diagnoses].

Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis.

Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.

Chest computed tomography: biomarkers and artificial intelligence,Tomodensitométrie thoracique : biomarqueurs et intelligence artificielle

Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection

Estimation of Regional Pulmonary Compliance in Idiopathic Pulmonary Fibrosis Based on Personalized Lung Poromechanical Modeling.

Airway replacement using stented aortic matrices: Long-term follow-up and results of the TRITON-01 study in 35 adult patients.

[French practical guidelines for the diagnosis and management of IPF - 2021 update, full version].

[French practical guidelines for the diagnosis and management of IPF - 2021 update, short version].

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study.

Pitfalls in Cancer Evaluation in Case of Chronic Superior Vena Cava Obstruction: Vertebral Enhancement and Hot Quadrate Sign in the Liver.

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.

Diagnosis Yield and Safety of Surgical Biopsy in Interstitial Lung Diseases: A Prospective Study.

Collaborators (11)

Salim Si-mohamed

Jean-François BERNAUDIN

Hannes Devos

Boris Duchemann

dominique Valeyre

Raphael Borie

Federica Cacciamani

Emmanuel Martinod

Patricia Van der Niepen

Thomas Gille

Yurdagul Uzunhan

Make your next move.